Needles in haystacks

American Journal of Gastroenterology

Volumn 102, Issue 11, 2007, Pages 2444-2446

  Reuben, Adrian ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BENZOQUINONE DERIVATIVE; BIOLOGICAL MARKER; CHLORPROMAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISONIAZID; MINOCYCLINE; N ACETYL 4 BENZOQUINONIMINE; NON PRESCRIPTION DRUG; PARACETAMOL; PHENYTOIN; PROPYLTHIOURACIL; PSYCHOTROPIC AGENT; UNCLASSIFIED DRUG; VALPROIC ACID;

CLINICAL PRACTICE; DATA BASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG INDUCED DISEASE; DRUG INDUCED LIVER INJURY; DRUG INFORMATION; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; GENOMICS; HIGH THROUGHPUT SCREENING; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LIVER INJURY; LIVER TOXICITY; MEDICAL RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; PROTEOMICS; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TRANSCRIPTOMICS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CAUSALITY; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; LIVER DISEASES; PHARMACEUTICAL PREPARATIONS; POPULATION SURVEILLANCE; UNITED STATES;

EID: 35448981061     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01450.x     Document Type: Review

References (16)

1. Reuben A. Hy's law. Hepatology 2004 39 : 574 8.
2. Biour M, Poupon R, Grangé JD, et al. Drug-induced hepatotoxicity. The 13th updated edition of the bibliographic database of drug-related liver injuries and responsible drugs. Gastroenterol Clin Biol 2000 24 : 1052 91.
3. Watkins PB, Seeff LB. Drug-induced liver injury: Summary of a single topic clinical research conference. Hepatology 2006 43 : 618 31.
4. Lee WM, Senior JR. Recognizing drug-induced liver injury: Current problems, possible solutions. Toxicol Pathol 2005 33 : 154 64.
5. Sgro C, Clinard F, Ouazir K, et al. Incidence of drug-induced hepatic injuries: A French population-based study. Hepatology 2002 36 : 451 5.
6. Friis H, Andreasen PB. Drug-induced hepatic injury: An analysis of 1100 cases reported to be the Danish Committee on Adverse Drug Reactions between 1978 and 1987. J Intern Med 1992 232 : 133 8.
7. U.S. Food and Drug Administration. Center for drug evaluation and research. Drug-induced liver injury: A national and global problem. Available at : http://www.fda.cov/cder/livertox/monday.htm. Accessed June 3, 2007.
8. Lee WM. Assessing causality in drug-induced liver injury. J Hepatol 2000 33 : 1003 5.
9. Davern JJ, James LP, Hinson JA, et al. Measurement of serum acetaminophen-protein adducts in patients with acute liver failure. Gastroenterology 2006 130 : 687 94.
10. Björnsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology 2005 42 : 481 9.
11. Andrade JR, Lucena MI, Kaplowitz N, et al. Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry. Hepatology 2006 44 : 1581 8.
12. Aithal PG, Day CP. The natural history of histologically proved drug induced liver disease. Gut 1999 44 : 731 45.
13. Ishida Y, Kondo T, Oshima T, et al. A pivotal involvement of IFN-γ in the pathogenesis of acetaminophen-induced acute liver injury. FASEB J 2002 16 : 1227 36.
14. Liu Z-X, Govindarajan S, Kaplowitz N. Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. Gastroenterology 2004 127 : 1760 74.
15. Liu Z-X, Han D, Gunawan B, et al. Neutrophil depletion protects against murine acetaminophen hepatotoxicity. Hepatology 2006 43 : 1220 30.
16. Hoofnagle JH. Drug-induced liver injury network (DILIN). Hepatology 2004 40 : 773.